Literature DB >> 15471558

Paradoxically enhanced immunoreactivity of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in cancer cells at the invasion front.

Koki Nagaike1, Kazuyo Kohama, Shuichiro Uchiyama, Hiroyuki Tanaka, Kazuo Chijiiwa, Hiroshi Itoh, Hiroaki Kataoka.   

Abstract

We have previously demonstrated significantly decreased immunoreactivity of hepatocyte growth factor activator inhibitor type 1 (HAI-1), an integral membrane protein that exhibits potent inhibitory activity against hepatocyte growth factor activator (HGFA) and matriptase, in colorectal adenocarcinomas. In this report, we describe further detailed analysis of HAI-1 expression in colorectal adenocarcinoma by using three kinds of anti-HAI-1 antibodies, each of which recognizes a distinct epitope of the HAI-1 molecule, and also by in-situ hybridization for HAI-1 mRNA. The results indicated that the decreased immunoreactivity of HAI-1 in colorectal carcinoma cells is largely a result of enhanced ectodomain shedding of HAI-1 in these cells. In contrast, immunoreactivity of mature membrane-form HAI-1 was paradoxically en-hanced in cancer cells at the invasion front, showing intense cell-stroma interactions and/or sprouting invasion. This finding indicates that these invading cells showed decreased ectodomain shedding of HAI-1 and consequently might require the existence of the membrane-form HAI-1. Of particular interest was the observation of a possible inverse correlation between paradoxical up-regulation of membrane-form HAI-1 expression and membrane-associated E-cadherin in these cells. These membrane-form HAI-1-positive sprouting cancer cells were also negative for MIB-1 immunohistochemically, indicating a low-proliferating population. All these results suggest that HAI-1 may mediate diverse functions in regard to the progression of colorectal carcinomas, and the immunoreactivity of membrane-form HAI-1 may serve as a marker of invading cancer cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471558     DOI: 10.1111/j.1349-7006.2004.tb03253.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  12 in total

1.  Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta.

Authors:  Hiroyuki Tanaka; Koki Nagaike; Naoki Takeda; Hiroshi Itoh; Kazuyo Kohama; Tsuyoshi Fukushima; Shiro Miyata; Shuichiro Uchiyama; Shunro Uchinokura; Takeshi Shimomura; Keiji Miyazawa; Naomi Kitamura; Gen Yamada; Hiroaki Kataoka
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

2.  Expression of hepatocyte growth factor activator inhibitor type 1 in endothelial cells.

Authors:  Yutaka Akiyama; Miyuki Nagai; Wataru Komaki; Kousuke Marutsuka; Yujiro Asada; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2006-08       Impact factor: 4.174

3.  Enhanced expression of hepatocyte growth factor activator inhibitor type 2-related small peptide at the invasive front of colon cancers.

Authors:  S Uchiyama; H Itoh; S Naganuma; K Nagaike; T Fukushima; H Tanaka; R Hamasuna; K Chijiiwa; H Kataoka
Journal:  Gut       Date:  2006-06-29       Impact factor: 23.059

4.  Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract.

Authors:  Lei Zeng; Jiang Cao; Xing Zhang
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

5.  Expression of serine peptidase inhibitor Kunitz type 1 in differentiated thyroid cancer.

Authors:  Chien-Liang Liu; Po-Sheng Yang; Ming-Nan Chien; Yuan-Ching Chang; Chi-Hsin Lin; Shih-Ping Cheng
Journal:  Histochem Cell Biol       Date:  2018-03-12       Impact factor: 4.304

6.  Expression of hepatocyte growth factor activator inhibitor type 1 on the epithelial cell surface is regulated by hypoxic and oxidative stresses.

Authors:  Wataru Komaki; Tsuyoshi Fukushima; Hiroyuki Tanaka; Hiroshi Itoh; Etsuo Chosa; Hiroaki Kataoka
Journal:  Virchows Arch       Date:  2008-09-04       Impact factor: 4.064

7.  Roles of Kunitz domains in the anti-invasive effect of hepatocyte growth factor activator inhibitor type 1 in human glioblastoma cells.

Authors:  Shiro Miyata; Tsuyoshi Fukushima; Kazuyo Kohama; Hiroyuki Tanaka; Hideo Takeshima; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2007-11       Impact factor: 4.174

8.  Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice.

Authors:  Koki Nagaike; Makiko Kawaguchi; Naoki Takeda; Tsuyoshi Fukushima; Akira Sawaguchi; Kazuyo Kohama; Mitsuru Setoyama; Hiroaki Kataoka
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

9.  Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein.

Authors:  Aaron C Mitchell; Deepti Kannan; Sean A Hunter; R Andres Parra Sperberg; Cheryl H Chang; Jennifer R Cochran
Journal:  J Biol Chem       Date:  2018-01-31       Impact factor: 5.157

10.  The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals.

Authors:  Lotte K Vogel; Mona Saebø; Camilla F Skjelbred; Kathrine Abell; Esben D K Pedersen; Ulla Vogel; Elin H Kure
Journal:  BMC Cancer       Date:  2006-07-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.